| UniProt ID | EIF1_HUMAN | |
|---|---|---|
| UniProt AC | P41567 | |
| Protein Name | Eukaryotic translation initiation factor 1 | |
| Gene Name | EIF1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 113 | |
| Subcellular Localization | ||
| Protein Description | Necessary for scanning and involved in initiation site selection. Promotes the assembly of 48S ribosomal complexes at the authentic initiation codon of a conventional capped mRNA.. | |
| Protein Sequence | MSAIQNLHSFDPFADASKGDDLLPAGTEDYIHIRIQQRNGRKTLTTVQGIADDYDKKKLVKAFKKKFACNGTVIEHPEYGEVIQLQGDQRKNICQFLVEIGLAKDDQLKVHGF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MSAIQNLH -------CCHHCCHH | 5.72 | - | |
| 2 | Acetylation | ------MSAIQNLHS ------CCHHCCHHH | 33.79 | 20068231 | |
| 2 | Phosphorylation | ------MSAIQNLHS ------CCHHCCHHH | 33.79 | 29255136 | |
| 9 | Phosphorylation | SAIQNLHSFDPFADA CHHCCHHHCCCCCCC | 34.21 | 25159151 | |
| 17 | Phosphorylation | FDPFADASKGDDLLP CCCCCCCCCCCCCCC | 37.41 | 28464451 | |
| 18 | Ubiquitination | DPFADASKGDDLLPA CCCCCCCCCCCCCCC | 68.99 | - | |
| 27 | Phosphorylation | DDLLPAGTEDYIHIR CCCCCCCCCCEEEEE | 27.99 | 28450419 | |
| 30 | Phosphorylation | LPAGTEDYIHIRIQQ CCCCCCCEEEEEEEE | 6.54 | 25159151 | |
| 42 | Ubiquitination | IQQRNGRKTLTTVQG EEECCCCEEEEEEEC | 49.65 | 21906983 | |
| 43 | Phosphorylation | QQRNGRKTLTTVQGI EECCCCEEEEEEECC | 28.16 | 22199227 | |
| 45 | Phosphorylation | RNGRKTLTTVQGIAD CCCCEEEEEEECCCC | 30.10 | 20068231 | |
| 46 | Phosphorylation | NGRKTLTTVQGIADD CCCEEEEEEECCCCC | 17.59 | 28555341 | |
| 54 | Phosphorylation | VQGIADDYDKKKLVK EECCCCCCCHHHHHH | 30.15 | 20068231 | |
| 56 | 2-Hydroxyisobutyrylation | GIADDYDKKKLVKAF CCCCCCCHHHHHHHH | 45.65 | - | |
| 58 | Acetylation | ADDYDKKKLVKAFKK CCCCCHHHHHHHHHH | 65.34 | 19608861 | |
| 61 | Acetylation | YDKKKLVKAFKKKFA CCHHHHHHHHHHHHC | 59.55 | 19608861 | |
| 66 | Ubiquitination | LVKAFKKKFACNGTV HHHHHHHHHCCCCEE | 38.49 | - | |
| 69 | S-nitrosocysteine | AFKKKFACNGTVIEH HHHHHHCCCCEEEEC | 5.63 | - | |
| 69 | S-nitrosylation | AFKKKFACNGTVIEH HHHHHHCCCCEEEEC | 5.63 | 22178444 | |
| 72 | Phosphorylation | KKFACNGTVIEHPEY HHHCCCCEEEECCCC | 12.34 | 27307780 | |
| 79 | Phosphorylation | TVIEHPEYGEVIQLQ EEEECCCCCCEEEEE | 24.04 | 27307780 | |
| 91 | Ubiquitination | QLQGDQRKNICQFLV EEECHHHHCHHHHHH | 45.06 | 21890473 | |
| 109 | Acetylation | LAKDDQLKVHGF--- CCCCCCCEECCC--- | 26.93 | 25953088 | |
| 109 | Ubiquitination | LAKDDQLKVHGF--- CCCCCCCEECCC--- | 26.93 | 21906983 | |
| 109 | 2-Hydroxyisobutyrylation | LAKDDQLKVHGF--- CCCCCCCEECCC--- | 26.93 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EIF1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EIF1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EIF1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| EIF2D_HUMAN | EIF2D | physical | 22939629 | |
| EIF3G_HUMAN | EIF3G | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-58 AND LYS-61, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-30, AND MASSSPECTROMETRY. | |